Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
- Status
- COMPLETED
- Phase
- NA
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
- Status
- COMPLETED
- Phase
- NA
MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
- Status
- COMPLETED
- Phase
- PHASE3
Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
- Status
- COMPLETED
- Phase
- NA
Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
- Status
- UNKNOWN
- Phase
- NA
Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
- Status
- UNKNOWN
- Phase
- PHASE3
Proteome-based Personalized Immunotherapy of Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab Beyond Progression (BBP)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Derivation of Tumor Specific Hybridomas
- Status
- TERMINATED
- Phase
- PHASE1
Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
- Status
- UNKNOWN
- Phase
- PHASE3
Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
- Status
- UNKNOWN
- Phase
- NA
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2